Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. is a leading provider of life science research and clinical diagnostic products, founded in 1952 and headquartered in Hercules, California, United States.
Snapshot
Bio-Rad Laboratories Inc. is a life sciences tools and services company that has completed 11 disclosed acquisitions and reported $2.58B in latest-year revenue.
- Sector
- Life Sciences Tools and Services
- Ticker
- BIO
- Revenue (LTM)
- $2.58B
- Acquisitions
- 11
- Operating margin
- 1.8%
- Latest call
- Q1 2026
Business description
Bio-Rad Laboratories Inc. is a leading provider of life science research and clinical diagnostic products, founded in 1952 and headquartered in Hercules, California, United States. The company generates revenue through advanced laboratory instruments, reagents, and software sold to research institutions, hospitals, and biopharma companies. Under the leadership of CEO Norman H. Schwartz, Bio-Rad continues to drive innovation with flagship products including the GelDoc and Bio-Plex systems. With strategic investments in digital automation and next-generation diagnostics, the firm is well-positioned for sustained global growth.
Everything on Bio-Rad Laboratories Inc.
Financials
Leadership & board
Acquisitions
Share repurchases
Bio-Rad's board authorized the 2023 Share Repurchase Program to repurchase up to $1.0 billion of common stock (a $500 million authorization in July 2023 plus an additional $500 million in July 2024), with $284.6 million remaining available as of December 31, 2025.